INBS secures a key U.S. patent, strengthening its IP protection and paving the way for 2025 market entry with innovative biometric technology.
The patent is crucial for the company's testing system, which detects drugs in fingerprint sweat utilising lateral flow technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback